Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Flamand

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Transplantation|December 30, 1998
Chronic rejection of major histocompatibility complex class II-disparate skin grafts after anti-CD3 therapy: a model of antibody-independent transplant vasculopathyA Le Moine, V Flamand, J C Noël, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1997
Fc epsilonRI gamma can support T cell development and function in mice lacking endogenous TCR zeta-chainE Shores, V Flamand, T Tran, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Vaccination with tumor-antigen-pulsed dendritic cells induces in vivo resistance to a B cell lymphomaV Flamand, T Sornasse, K Thielemans, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 14, 2011
Th17 alloimmunity prevents neonatal establishment of lymphoid chimerism in IL-4-deprived miceI Debock, S Delbauve, A Dubois, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 4, 2017
[Salvage radical prostatectomy for recurrent prostate cancer. Morbidity, oncological and functional results]R Vidmar, G Marcq, V Flamand, et al.
Immunity|May 20, 1998
Allergy-associated FcRbeta is a molecular amplifier of IgE- and IgG-mediated in vivo responsesD Dombrowicz, S Lin, V Flamand, et al.
International Journal of Cancer|April 15, 1990
Immune surveillance: both CD3+ CD4+ and CD3+ CD8+ T cells control in vivo growth of P815 mastocytomaV Flamand, C Biernaux, M Van Mechelen, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Loading of dendritic cells with antigen in vitro or in vivo by immunotargeting can replace the need for adjuvantT Sornasse, V Flamand, G De Becker, et al.
The Journal of Clinical Investigation|March 1, 1997
Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chainsD Dombrowicz, V Flamand, I Miyajima, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 24, 2015
[Long term biochemical recurrence free survival after radical prostatectomy for cancer: comparative analysis according to surgical approach and clinicopathological stage]J Rizk, A Ouzzane, V Flamand, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Transplantation|December 30, 1998
Chronic rejection of major histocompatibility complex class II-disparate skin grafts after anti-CD3 therapy: a model of antibody-independent transplant vasculopathyA Le Moine, V Flamand, J C Noël, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1997
Fc epsilonRI gamma can support T cell development and function in mice lacking endogenous TCR zeta-chainE Shores, V Flamand, T Tran, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Vaccination with tumor-antigen-pulsed dendritic cells induces in vivo resistance to a B cell lymphomaV Flamand, T Sornasse, K Thielemans, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 14, 2011
Th17 alloimmunity prevents neonatal establishment of lymphoid chimerism in IL-4-deprived miceI Debock, S Delbauve, A Dubois, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 4, 2017
[Salvage radical prostatectomy for recurrent prostate cancer. Morbidity, oncological and functional results]R Vidmar, G Marcq, V Flamand, et al.
Immunity|May 20, 1998
Allergy-associated FcRbeta is a molecular amplifier of IgE- and IgG-mediated in vivo responsesD Dombrowicz, S Lin, V Flamand, et al.
International Journal of Cancer|April 15, 1990
Immune surveillance: both CD3+ CD4+ and CD3+ CD8+ T cells control in vivo growth of P815 mastocytomaV Flamand, C Biernaux, M Van Mechelen, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Loading of dendritic cells with antigen in vitro or in vivo by immunotargeting can replace the need for adjuvantT Sornasse, V Flamand, G De Becker, et al.
The Journal of Clinical Investigation|March 1, 1997
Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chainsD Dombrowicz, V Flamand, I Miyajima, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 24, 2015
[Long term biochemical recurrence free survival after radical prostatectomy for cancer: comparative analysis according to surgical approach and clinicopathological stage]J Rizk, A Ouzzane, V Flamand, et al.
Pageof 5